Training of patients for self-management of oral anticoagulant therapy:: Standards, patient suitability, and clinical aspects

被引:28
作者
Mörsdorf, S [1 ]
Erdlenbruch, W
Taborski, U
Schenk, JF
Erdlenbruch, K
Novotny-Reichert, G
Krischek, B
Wenzel, E
机构
[1] Univ Clin Saarland, Dept Clin Haemostaseol & Transfus Med, D-66421 Homburg, Germany
[2] Kerckhoff Klin, Dept Hemostaseol & Transfus Med, Bad Nauheim, Germany
[3] Fachklin Fruhrehabil, Abt Kardiol, Quierschied Saar, Germany
关键词
oral anticoagulants; home-monitoring; self-management; patient training; INR;
D O I
10.1055/s-2007-996433
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Self-control and self-management of oral anticoagulant therapy have become more and more attractive for patients undergoing long-term treatment. In our training center, we examined 50 patients who took part in a standardized training course for self-management. Patients (36 men, 14 women) were preselected according to the guidelines of the German Association for Self-management of Oral Anticoagulation (ASA e.V.) and were all trained by the same physician. The complete course took an average of eight sessions, Patients older than 59 years needed significantly more training time in theoretical advising than younger patients; they did not need more training time in practical matters. The values between International Normalized Ratio (INR) measured in venous blood samples and by self-assessment were comparable for both groups. There was a good overall correlation between self-controlled INRs and laboratory assays, however, the self-assayed INRs were significantly lower than those from the venous blood samples.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 36 条
[31]  
TABORSKI U, 1992, ANN HEMATOL, V64, pA18
[32]   Multicenter evaluation of a new capillary blood prothrombin time monitoring system [J].
vandenBesselaar, AMHP ;
Breddin, K ;
Lutze, G ;
ParkerWilliams, J ;
Taborski, U ;
Vogel, G ;
Tritschler, W ;
Zerback, R ;
Leinberger, R .
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (08) :726-732
[33]   The role of compliance as a cause of instability in oral anticoagulant therapy [J].
vanderMeer, FJM ;
Briet, E ;
Vandenbroucke, JP ;
Sramek, DI ;
Versluijs, MHPM ;
Rosendaal, FR .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) :893-900
[34]   HOME PROTHROMBIN TIME MONITORING AFTER THE INITIATION OF WARFARIN THERAPY - A RANDOMIZED, PROSPECTIVE-STUDY [J].
WHITE, RH ;
MCCURDY, SA ;
VONMARENSDORFF, H ;
WOODRUFF, DE ;
LEFTGOFF, L .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (09) :730-737
[35]   OUTPATIENT USE OF A PORTABLE INTERNATIONAL NORMALIZED RATIO/PROTHROMBIN TIME MONITOR [J].
WHITE, RH ;
BECKER, DM ;
GUNTHERMAHER, MG .
SOUTHERN MEDICAL JOURNAL, 1994, 87 (02) :206-210
[36]  
WITTSTAMM FJ, 1992, Z KARDIOL, V81, P176